| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 1.864 | 1.090 | 0 | 1.051 | 353 | 124 | 122 | 122 | 82 | 0 |
| Gross Profit/Loss - EUR | -1.864 | -1.090 | 0 | -1.051 | -353 | -124 | -122 | -122 | -82 | 0 |
| Net Profit/Loss - EUR | -1.864 | -1.090 | 0 | -1.051 | -353 | -124 | -122 | -122 | -82 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dermatin S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.220 | 2.988 | 2.938 | 780 | 412 | 280 | 152 | 30 | 0 | 0 |
| Current Assets | 58 | 57 | 56 | 55 | 54 | 53 | 52 | 52 | 0 | 0 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 58 | 57 | 56 | 55 | 54 | 53 | 52 | 52 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -36.472 | -38.279 | -37.632 | -39.044 | -38.641 | -38.033 | -37.311 | -37.549 | -37.518 | -37.308 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 41.751 | 41.325 | 40.625 | 39.880 | 39.108 | 38.366 | 37.515 | 37.632 | 37.518 | 37.308 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2361 - 2361" | |||||||||
| CAEN Financial Year |
1419
|
|||||||||
Comments - Dermatin S.r.l.